The following supplements may help people with Graves disease: Selenium
This cognitive relief can be transformative for people who have struggled with willpower-based approaches
The closest human evidence in its drug class is Athira Pharma's fosgonimeton (ATH-1017), a structurally distinct molecule in the same HGF/c-Met program whose Phase 2/3 LIFT-AD Alzheimer's trial failed its primary endpoint in September 2024 (GST 0.08, P=.70)
Combination of everolimus with exemestrane is an effective treatment for ER + /ErbB2 - breast cancer
Substantial weight loss may reduce knee loading and improve symptoms, but clinically relevant loss of lean mass may worsen sarcopenia, quadriceps weakness, balance, walking capacity, and postoperative recovery
HSA and FSA accounts cover tirzepatide and semaglutide through PlexusDx, making preventive care more affordable